Trial Profile
Phase I Study of Oral Darinaparsin in Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Darinaparsin (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Alaunos Therapeutics
- 08 May 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
- 08 May 2012 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 08 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.